Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-97-008776
Filing Date
1997-12-24
Accepted
1997-12-24 00:00:00
Documents
9
Period of Report
1997-09-30
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 110447
2 EXHIBIT 10.15 EMPLOYMENT AGMT. WITH GEHLSEN EX-10.15 18660
3 EXHIBIT 10.16 EMPLOYMENT AGMT. WITH SANDER EX-10.16 19771
4 EXHIBIT 10.17 EMPLOYMENT AGMT. WITH STAMBAUGH EX-10.17 12808
5 EXHIBIT 11.1 COMP. OF LOSS EX-11.1 2196
6 EXHIBIT 13.1 ANNUAL REPORT EX-13.1 117396
7 EXHIBIT 23.1 CONSENT OF KPMG EX-23.1 952
8 EXHIBIT 27.1 EX-27.1 2296
9 EXHIBIT 99.1 REPORT OF KPMG EX-99.1 2041
  Complete submission text file 0001047469-97-008776.txt   288900
Mailing Address 4350 EXECUTIVE DR STE 310 SAN DIEGO CA 92121
Business Address 3099 SCIENCE PK RD STE 150 SAN DIEGO CA 92121 6194534040
MAXIM PHARMACEUTICALS INC (Filer) CIK: 0001013351 (see all company filings)

EIN.: 870279983 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-14430 | Film No.: 97743985
SIC: 2833 Medicinal Chemicals & Botanical Products